# Task #019 decision-context framework summary

**Decision contexts:** 3  
**Evidence-context relationships:** 24  
**Evidence-type interpretation boundaries:** 17  
**Validation checks passed:** 8/8  
**Gene or target evaluation performed:** No

## Contexts

### Biological Discovery

**Question:** Is this gene worth further biological investigation?

**Required domains:** `DOM_TRANSCRIPTOMIC_DISCOVERY|DOM_DISEASE_ASSOCIATION`

This context can justify additional biological investigation when LUAD-linked molecular observations are traceable and coherent. It cannot establish causality, drug efficacy, safety, clinical benefit, or a therapeutic mechanism.

### Therapeutic Development

**Question:** Does this target have evidence relevant to drug development feasibility?

**Required domains:** `DOM_PHARMACOLOGY|DOM_TRACTABILITY|DOM_SAFETY`

This context describes whether source-grounded pharmacology, modality feasibility, and risk information are available for development planning. It cannot establish biological causality, therapeutic efficacy, acceptable dose, or clinical success.

### Translational Context

**Question:** Is there evidence supporting potential clinical relevance?

**Required domains:** `DOM_DISEASE_ASSOCIATION|DOM_PHARMACOLOGY|DOM_CLINICAL_DEVELOPMENT|DOM_SAFETY`

This context describes traceable disease relevance, intervention linkage, human development evidence, and risk context. It cannot establish efficacy, approval, patient benefit, clinical utility, or a favorable benefit-risk balance.

## Support-role counts

| Context | Required | Relevant | Optional | Not applicable |
| --- | ---: | ---: | ---: | ---: |
| Biological Discovery | 2 | 2 | 2 | 2 |
| Therapeutic Development | 3 | 4 | 1 | 0 |
| Translational Context | 4 | 4 | 0 | 0 |

## Central interpretation rules

- `REQUIRED` means the domain must be adequately characterized before the stated context can be interpreted as supported. It is not a numerical weight.
- Missing required evidence leaves the context unresolved; it does not count against the gene and is not negative evidence.
- `RELEVANT` qualifies or challenges the interpretation but cannot substitute automatically for a required domain.
- `OPTIONAL` can add context but is neither necessary nor sufficient for the context question.
- `NOT_APPLICABLE` means the domain does not directly support that specific question; its evidence remains available for other contexts.
- Evidence counts and multiple fields from shared sources are not independent votes.
- Every interpretation must retain record, source, release/query, dependency lineage, and frozen artifact hash.

## Evidence generation versus decision interpretation

This framework defines which evidence can inform each question and the maximum conclusion allowed from each evidence type. It does not retrieve, generate, transform, or aggregate scientific evidence. Four ontology types—cancer genetics, CRISPR dependency, compound-target evidence, and trial-level development—remain future-compatible and `NOT_QUERIED` in the current architecture.

## Explicit non-claims

No gene was assessed. No evidence was converted into a score, ordering, candidate selection, target recommendation, intervention mechanism, or therapeutic direction. The framework does not establish causality, efficacy, safety, clinical benefit, or a benefit-risk balance.
